State ID
Clinical Trials in Idaho
Recruiting clinical trials with at least one study location in Idaho. Data updated daily from ClinicalTrials.gov.
Top Conditions in Idaho
NCT06914908 Phase 2
Recruiting
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants Wit...
Condition
Chronic Rhinosinusitis With Nasal Polyps
Enrollment
64 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT06897475 Phase 2
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes ...
Condition
Type 2 Diabetes
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Eli Lilly and Company
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07195695 Phase 3
Recruiting
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically...
Condition
Non-small Cell Lung Cancer
Enrollment
400 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT06902558 Phase 2
Recruiting
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of A...
Condition
Autosomal Dominant Polycystic Kidney Disease
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer